BWXT or OKLO: Which Nuclear Stock Should You Choose and Why?
π BWXT maintains an $8.4 billion backlog in naval propulsion and commercial nuclear equipment, indicating demand outpacing deliveries.
π° BWXT expects to generate between $345 million and $360 million in free cash flow for 2026, funding expansion without heavy reliance on external financing.
π€ OKLO has secured a major customer commitment from Meta for its 1.2-gigawatt reactor deployment on an Ohio campus.
βοΈ OKLO successfully reached criticality at its Groves isotope test reactor in less than a year, validating execution capabilities.
ποΈ OKLO's Groves-2 Forge project was selected for the Department of Energy's Nuclear Energy Launch Pad initiative to produce isotopes like lutetium-177.
β½ OKLO has a letter of intent with Centrus for fuel supply up to five Aurora powerhouses, with potential deliveries starting in 2029.
πΈ OKLO held $3 billion in cash and marketable securities at the end of the second quarter to fund its development activities.
π OKLO incurred an expected loss of $1.01 per share for 2026, representing a 40.3% widening compared to the prior year.
π BWXT's stock price declined 35.6% over six months while outperforming OKLO, which fell 58% during the same period.
π― Analyst consensus estimates project BWXT earnings of $4.75 per share for 2026, up 18.5% from 2025 reported numbers.
- OKLO has secured a definitive customer commitment from Meta to deploy its 1.2-gigawatt reactor on an Ohio campus.
- The company demonstrated successful execution by reaching criticality at its Groves isotope test reactor in less than one year.
- OKLO's Groves-2 Forge project was selected for the Department of Energy's Nuclear Energy Launch Pad initiative to produce medical isotopes.
- OKLO holds $3 billion in cash and marketable securities, providing substantial liquidity for development and operations.
- Analysts expect OKLO to incur a loss of $1.01 per share in 2026, which is 40.3% wider than the year-ago figure.
- OKLO's commercial power plans face significant hurdles regarding construction completion and regulatory startup authorization.
- The company has not yet established the economics of commercial electricity generation despite success with its isotope test reactor.